Guidelines on the use of finasteride in androgenetic alopecia
| Autor: | BM Shashikumar, Venkataram Mysore |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Male
medicine.medical_specialty Sexual Behavior MEDLINE Dermatology sexual side effects law.invention 030207 dermatology & venereal diseases 03 medical and health sciences chemistry.chemical_compound 5-alpha Reductase Inhibitors 0302 clinical medicine Randomized controlled trial law lcsh:Dermatology medicine Humans Prospective Studies guidelines Adverse effect Androgenetic alopecia Randomized Controlled Trials as Topic Retrospective Studies Gynecology United States Food and Drug Administration business.industry Alopecia Retrospective cohort study lcsh:RL1-803 medicine.disease United States finasteride Infectious Diseases Hair loss Systematic review chemistry 030220 oncology & carcinogenesis Practice Guidelines as Topic Finasteride Female Male-pattern baldness business |
| Zdroj: | Indian Journal of Dermatology, Venereology and Leprology, Vol 82, Iss 2, Pp 128-134 (2016) |
| ISSN: | 0378-6323 |
| DOI: | 10.4103/0378-6323.177432 |
| Popis: | Background: Finasteride is a widely used drug in dermatology for the treatment of androgenetic alopecia. There are many reports of associated sexual side effects. This article reviews the use of once-daily 1 mg finasteride in androgenetic alopecia and its associated sexual adverse effects. Methods: A literature search was performed to collect data on the use of finasteride in male pattern baldness. Relevant literature published till March 2014 was obtained from MEDLINE, EMBASE, CINAHL, Cochrane registers and LILACS. The keywords "finasteride", "male pattern baldness" and "androgenetic alopecia" were used for literature search. Similarly, a search was done for finasteride in female pattern hair loss with keywords "female pattern baldness", "finasteride" and "female pattern alopecia". All systematic reviews, meta-analyses, national guidelines, randomized controlled trials, prospective open label studies and retrospective case series in the English literature were reviewed. Results: Two hundred sixty two studies were evaluated, twelve of which fulfilled the inclusion criteria. Conclusions and Recommendations: Current evidence on the safety of finasteride indicates that it is safe but there is growing concern about its sexual side effects. In view of this, proper information should be provided to patients prior to starting treatment (Level of recommendation 1+, Grade of recommendation B). The reported sexual side effects are few and reverse with stoppage of the drug (Grade of recommendation B) but further studies are required. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|